Johnson & Johnson: A solid dividend stock

Johnson & Johnson: Dividend Stock Analysis


Overall, I feel that despite the recent string of recalls that has tarnished the company’s reputation, there is significant value in this company and stock. A perfect storm of the financial collapse and health care reform in the United States, along with near-simultaneous internal company problems with McNeil, has resulted in uncharacteristically lackluster performance of the company, and a historically low valuation of the stock. I conclude that over the long term, JNJ is a solid buy at the current price.

Comment: I could see investing in Johnson and Johnson / JNJ

No comments:

Post a Comment

Any anonymous comments with links will be rejected. Please do not comment off-topic